{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T21:19:15Z","timestamp":1790543955931,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbmt.2016.02.017","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T12:49:27Z","timestamp":1457441367000},"page":"1094-1101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors"],"prefix":"10.1016","volume":"22","author":[{"given":"Kasey J.","family":"Leger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Cushing-Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy M.","family":"Leisenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lue Ping","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-961X","authenticated-orcid":false,"given":"Eric J.","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.02.017_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","article-title":"Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study","volume":"19","author":"Sun","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.02.017_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cncr.28444","article-title":"Cardiovascular disease in survivors of hematopoietic cell transplantation","volume":"120","author":"Armenian","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2016.02.017_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-155-1-201107050-00004","article-title":"Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation","volume":"155","author":"Chow","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2016.02.017_bib4","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1182\/blood-2011-06-358226","article-title":"Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation","volume":"118","author":"Armenian","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.02.017_bib5","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.02.017_bib6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bbmt.2014.02.012","article-title":"Late cardiovascular complications after hematopoietic cell transplantation","volume":"20","author":"Chow","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.02.017_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1200\/JCO.2013.52.6582","article-title":"Influence of conventional cardiovascular risk factors and lifestyle characteristics on cardiovascular disease after hematopoietic cell transplantation","volume":"32","author":"Chow","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib8","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","article-title":"NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity","volume":"112","author":"Wojnowski","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.bbmt.2016.02.017_bib9","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1002\/cncr.23534","article-title":"Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer","volume":"112","author":"Blanco","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2016.02.017_bib10","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1080\/10428190903177212","article-title":"Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood","volume":"50","author":"Rajic","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2016.02.017_bib11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/leu.2008.398","article-title":"Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21","volume":"23","author":"Rossi","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2016.02.017_bib12","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes\u2013a report from the Children's Oncology Group","volume":"30","author":"Blanco","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib13","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2010.34.3467","article-title":"Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children","volume":"30","author":"Visscher","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/pbc.24505","article-title":"Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children","volume":"60","author":"Visscher","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.bbmt.2016.02.017_bib15","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/cncr.28256","article-title":"Impact of hemochromatosis gene mutations on cardiac status in doxorubicin-treated survivors of childhood high-risk leukemia","volume":"119","author":"Lipshultz","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2016.02.017_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/bjh.12516","article-title":"Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation","volume":"163","author":"Armenian","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib17","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2013.50.3557","article-title":"Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group","volume":"32","author":"Wang","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib18","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2015.63.4550","article-title":"CELF4 variant and anthracycline-related cardiomyopathy: a Children's Oncology Group genome-wide association study","volume":"34","author":"Wang","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib20","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1182\/blood-2011-09-371153","article-title":"Evaluation of published single nucleotide polymorphisms associated with acute GVHD","volume":"119","author":"Chien","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.02.017_bib21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2307\/2531051","article-title":"On the design of synthetic case-control studies","volume":"42","author":"Prentice","year":"1986","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2016.02.017_bib22","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1200\/JCO.2003.04.100","article-title":"Risk of secondary leukemia after a solid tumor in childhood according to the dose of epipodophyllotoxins and anthracyclines: a case-control study by the Societe Francaise d'Oncologie Pediatrique","volume":"21","author":"Le Deley","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib23","first-page":"CD005006","article-title":"Different anthracycline derivates for reducing cardiotoxicity in cancer patients","volume":"5","author":"van Dalen","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bbmt.2016.02.017_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.2009.978-a","article-title":"Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data","volume":"302","author":"Vasan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.bbmt.2016.02.017_bib25","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCGENETICS.109.898395","article-title":"Common variants in HSPB7 and FRMD4B associated with advanced heart failure","volume":"3","author":"Cappola","year":"2010","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.bbmt.2016.02.017_bib26","doi-asserted-by":"crossref","first-page":"e1001167","DOI":"10.1371\/journal.pgen.1001167","article-title":"Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy","volume":"6","author":"Stark","year":"2010","journal-title":"PLoS Genet"},{"key":"10.1016\/j.bbmt.2016.02.017_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A\u00a0genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy","volume":"32","author":"Villard","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bbmt.2016.02.017_bib28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/CIRCGENETICS.110.959205","article-title":"Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy","volume":"4","author":"Horne","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.bbmt.2016.02.017_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","article-title":"A\u00a0genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy","volume":"35","author":"Meder","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bbmt.2016.02.017_bib30","series-title":"BRLMM: an improved genotype calling method for the GeneChip Human\u00a0Mapping 500k array set","year":"2006"},{"key":"10.1016\/j.bbmt.2016.02.017_bib31","unstructured":"Illumina GenCall data analysis software. 2005. Available at: http:\/\/www.illumina.com\/Documents\/products\/technotes\/technote_gencall_data_analysis_software.pdf. Accessed January 28,\u00a02016."},{"key":"10.1016\/j.bbmt.2016.02.017_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2156-13-6","article-title":"Sequencing genes in silico using single nucleotide polymorphisms","volume":"13","author":"Zhang","year":"2012","journal-title":"BMC Genet"},{"key":"10.1016\/j.bbmt.2016.02.017_bib33","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib34","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2307\/2533444","article-title":"Robust variance estimation for the case-cohort design","volume":"50","author":"Barlow","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.bbmt.2016.02.017_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2016.02.017_bib36","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1200\/JCO.2013.49.3205","article-title":"Modifiable risk factors and major cardiac events among adult survivors of childhood cancer","volume":"31","author":"Armstrong","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.02.017_bib37","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.bbmt.2011.08.003","article-title":"Hyperlipidemia and statin use after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Blaser","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.02.017_bib38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/pds.3660","article-title":"Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment","volume":"24","author":"Calip","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bbmt.2016.02.017_bib39","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","article-title":"Genetic power calculator: design of linkage and association genetic mapping studies of complex traits","volume":"19","author":"Purcell","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bbmt.2016.02.017_bib40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0090-9556(25)00245-4","article-title":"Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography","volume":"8","author":"Andrews","year":"1980","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.bbmt.2016.02.017_bib41","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.fpc.0000114771.78957.cb","article-title":"Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells","volume":"14","author":"Nagar","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.bbmt.2016.02.017_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng875","article-title":"Cardiac troponin T is essential in sarcomere assembly and cardiac contractility","volume":"31","author":"Sehnert","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbmt.2016.02.017_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/nature08494","article-title":"Finding the missing heritability of complex diseases","volume":"461","author":"Manolio","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.bbmt.2016.02.017_bib44","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa0706728","article-title":"Polymorphisms associated with cholesterol and risk of cardiovascular events","volume":"358","author":"Kathiresan","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.bbmt.2016.02.017_bib45","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1002\/sim.6600","article-title":"Combining large number of weak biomarkers based on AUC","volume":"34","author":"Yan","year":"2015","journal-title":"Stat Med"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116001415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116001415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:29Z","timestamp":1761058529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116001415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S1083879116001415"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.02.017","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}